Searched for
INDIA IND VACCINATION
Covaxin to be evaluated as COVID-19 vaccine candidate in US: Bharat BiotechCovaxin has already been granted Emergency Use Listing (EUL) in 13 countries as on January 31 according to the WHO. Covaxin was granted EUL...19 Feb, 2022, 07.39 PM IST- Bharat Biotech's US partner Ocugen files request with FDA for Covaxin trialsThe US firm in a press release said the Phase 3 trial, proposed in the IND, is designed to establish whether the immune response experience...27 Oct, 2021, 06.22 PM IST
- States’ fiscal deficit may fall to 4.1% of GDP in FY22: Ind-RaThe revenue receipts of state governments are expected to improve, backed by an economic recovery, resulting from a large section of the po...27 Aug, 2021, 11.43 PM IST
- Bharat Biotech, IVI launch Chikungunya Vaccine Phase 2/3 trial in Costa RicaCEPI first partnered with IVI and Bharat Biotech in June 2020, providing up to USD 14.1 million for vaccine manufacturing and clinical deve...25 Aug, 2021, 11.15 AM IST
- India Ratings cuts FY22 GDP growth forecast to 9.4% from 9.6%“Going by the pace of vaccination, it is now almost certain that India will not be able to vaccinate its entire adult population by Decembe...19 Aug, 2021, 04.22 PM IST
- India Ratings revises India's FY22 GDP growth to 9.4%; links forecast to vaccination driveThe forecast could further slip to 9.1% if India is unable to vaccinate it's entire adult population by December 31. However, if India does...19 Aug, 2021, 03.31 PM IST
- Phoenix Mills vaccinates 15,000 personnel across malls, residential, office projectsThe company has organized vaccination drives covering its employees, their family members, retail staff, contractual staff and third-party ...14 Jun, 2021, 02.30 PM IST
- Ind Ra revises down India's FY22 GDP growth forecast to 10.1 per centAt a time when large parts of the country are experiencing tremendous pressure on medical infrastructure, the agency said it expects the se...23 Apr, 2021, 01.40 PM IST
- Cost of vaccinating India's entire population above 18 years 0.36% of GDP: India Ratings and ResearchOut of the Rs 46,323 lakh crore that the states would have to spend on vaccinating those in the 18-44 age group, the highest burden would f...23 Apr, 2021, 12.38 PM IST
- Vaccine approvals lift Sensex by 660 ptsBut new restrictions in Maharashtra may hurt sentiment, investors to see what other states do: Experts14 Apr, 2021, 10.02 AM IST
- Africa CDC opposes issuance of COVID-19 passports citing inequitable access to vaccinesVaccine passports are documentation showing travellers have been vaccinated against COVID-19 or recently tested negative for the virus. Tec...08 Apr, 2021, 04.49 PM IST
- India Ratings revises FY21 GDP growth expectation to minus 7.8% from minus 11.8%Ind-Ra now expects 3Q FY21 GDP growth to come in at negative 0.8 per cent and 4Q FY21 GDP growth to turn positive at 0.3 per cent as agains...24 Dec, 2020, 01.54 PM IST
- When the pandemic hit, India's healthcare industry was quick to adapt to the need of the hourIndian diagnostic companies had experience in developing test assays for dengue, HIV, TB and H1N1, but with Covid-19 the delay in getting h...26 Nov, 2020, 09.29 AM IST
- Pandemic: When the going gets tough, innovators step up their gameIndian diagnostic companies had experience in developing test assays for dengue, HIV, TB and H1N1, but with Covid-19 the delay in getting h...25 Nov, 2020, 11.31 PM IST
- India launches programme to strengthen clinical trial research capacity of vaccines in neighbouring countriesThe training programme which will extend for about six to eight weeks will see participation of investigators, epidemiologists, clinicians ...23 Sep, 2020, 05.53 PM IST
- Human clinical trials of Gennova’s mRNA COVID-19 vaccine to start by the end of this yearPune-based biotechnology company Gennova Biopharmaceuticals will soon start human clinical trials of a Covid-19 vaccine candidate, joining ...20 Jul, 2020, 07.02 PM IST
- GSK Pharma trying to find out what ammunition is needed to grow: MDThe Indian arm of British drugmaker GlaxoSmithKline (GSK) is planning a major initiative to wrestle back ground it had conceded.01 Oct, 2015, 05.00 PM IST
Load More
